News & Updates

Show Multimedia Only
Glaucoma risk modestly low in diabetes

Glaucoma risk modestly low in diabetes

04 Sep 2022

Patients with diabetes mellitus are at reduced risk of developing open-angle glaucoma (OAG), although the magnitude of reduction is modest, according to a study.

04 Sep 2022
Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects

Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects

02 Sep 2022

Compared with dapagliflozin, the glucagon-like peptide 1 liraglutide induces better lipid metabolism in patients with type 2 diabetes mellitus (T2DM), a recent study has found. However, this drug also comes with more adverse events than its sodium-glucose co-transporter 2 inhibitor comparator.

02 Sep 2022